Chennai, 12th February, 2025: Lifesigns, a pioneer in intelligent patient monitoring solutions, has secured funding from Healthcare Capital, the investment arm of the Kauvery Hospital Group. The funding underscores Kauvery Hospital's deep trust in Lifesigns’ technology, having been an early adopter and clinical partner in the company’s journey.

The investment will primarily advance Lifesigns’ AI and predictive algorithm capabilities, further enhancing its proprietary patient monitoring platform. Lifesigns remains the only solution offering USFDA-approved hardware, software, dashboard, and AI integration, delivering proactive alerts and predictive insights across the patient journey—from ambulances to hospitals and home care. 

Our journey with Kauvery Hospital has been more than just a customer relationship—it has been a partnership in innovation. This investment from Healthcare Capital is a testament to the trust they place in our technology and its impact on healthcare outcomes,” said Hari Subramaniam, Founder and CEO of Lifesigns. “With this funding, we aim to push the boundaries of AI-driven patient monitoring, empowering healthcare professionals with predictive tools that eliminate uncertainty and enable confident decision-making.” 

Healthcare Capital, backed by over 25 years of expertise in the healthcare sector, brings deep industry knowledge and a commitment to enhancing patient care through cutting-edge technology. By investing in Lifesigns, Healthcare Capital reinforces its vision of integrating best-in-class innovations to improve patient outcomes and streamline healthcare workflows.

“As a healthcare provider, we understand the critical need for advanced monitoring solutions that enhance patient safety and ease the burden on healthcare professionals,” Dr Aravindan Selvaraj, Executive Director, Kauvery Hospital and Healthcare Capital. “Lifesigns’ technology is a game-changer, and we are excited to support their mission in redefining patient monitoring with AI-powered predictive analytics.” 

While Lifesigns continues to focus on AI advancements, the company is also gearing up for its next funding round in the next couple of months, where it plans to unveil new tech product and market expansion initiatives. With this strategic investment, Lifesigns is set to accelerate innovation, solidify its position as a leader in health tech, and contribute to shaping the future of patient monitoring.

About Lifesigns:

Lifesigns is a pioneer in intelligent patient monitoring solutions, committed to transforming healthcare delivery through state-of-the-art technology. Specializing in remote patient monitoring, wireless wearable devices, and predictive analytics. Lifesigns delivers scalable, secure, and seamless solutions tailored to the unique needs of healthcare professionals and institutions.

Lifesigns’ innovative platforms integrate effortlessly with existing healthcare systems to provide real-time insights, early warning alerts, and enhanced patient care: empowering healthcare teams to deliver exceptional outcomes even in the most challenging environments.

Since its inception in 2020, Lifesigns has successfully deployed its solutions across private and government hospitals in India, as well as in public health initiatives. Guided by a mission to equip healthcare providers with intelligent tools for more accurate decision-making in a shorter time, Lifesigns continues to redefine standards in predictive analytics. Notably, it is the only FDA-approved solution in India encompassing software, hardware, and AI, cementing its position as a trusted leader in the healthcare technology landscape.